13 FACT FINDERS: Baby’s symptoms were vaccine reaction, not measles
At the start of April, the count of confirmed measles cases across the U.S. passed 500, according to the CDC.There are ...
Vaxcyte stock sinks despite Phase II IPD vaccine trial success
Vaxcyte’s stock has dropped around 45% despite a Phase II trial of its invasive pneumococcal disease (IPD) vaccine meeting ...
Vaxcyte plunges despite pneumonia shot results as Marks departure weighs
Vaxcyte plunges 56% even though its VAX-24 pneumonia vaccine shows positive phase two results in infants. Read more here.
Vaxcyte Plans To Drop Developing One Pneumococcal Conjugate Vaccine
Vaxcyte's VAX-24 Phase 2 trial showed a safety profile similar to PCV20, with strong immune responses and no serious ...
Pharmabiz6d
Merck’s Capvaxive receives European approval for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults
Merck’s Capvaxive receives European approval for prevention of invasive pneumococcal disease and pneumococcal pneumonia in adults: Rahway, New Jersey Friday, March 28, 2025, 09: ...